Ohio Medical Cannabis at Seven Years: The 2016 Law, 2019 Rollout, and Issue 2
Ohio's medical marijuana program predates adult-use by nearly a decade. Authorized in 2016, opened to patients in 2019, and preserved alongside the 2023 Issue 2 adult-use vote — the medical program shaped the operators, infrastructure, and retail culture that now define Ohio cannabis. This is its short history.
House Bill 523 (2016)
Ohio's medical marijuana law was enacted by the state legislature in June 2016 as House Bill 523. The bill was in part a legislative response to an organized patient-advocacy push and in part a pre-emptive response to an anticipated citizen initiative. HB 523 established a limited medical marijuana program with a defined list of qualifying conditions, a state-administered licensing framework, and a three-agency regulatory structure that split oversight between the Department of Commerce (cultivators and processors), the State Medical Board (patient certification), and the Board of Pharmacy (dispensaries).
Slow Rollout: 2016–2019
The statutory deadline for fully operational medical sales was September 2018, but the actual launch was delayed. Licensing disputes, litigation, and implementation challenges pushed the first dispensary sales to January 16, 2019 — roughly four months past the statutory target. The first dispensaries to open were in Wintersville and Canton, with Cincinnati-area dispensaries coming online over the subsequent months.
How the Medical Program Worked
Patients with qualifying conditions — a list that grew over time and at various points included chronic pain, cancer, PTSD, epilepsy, multiple sclerosis, and others — could apply through a certified physician for a patient recommendation. With a recommendation, patients registered in the state's patient registry, received an Ohio medical marijuana patient ID, and could shop at licensed dispensaries for up to a 90-day supply at a time.
Medical patients paid a state registration fee (with indigence waivers available) and regular state sales tax on purchases. The medical program did not include the 10% adult-use excise tax that was later introduced under Issue 2. Medical patients had access to specific product formats and higher purchase caps than later adult-use consumers.
Operators and Licenses
Ohio's medical program was structured around a limited number of licenses issued competitively to a defined set of cultivators, processors, and dispensaries. The license caps generated significant political and legal activity — disputes over who received licenses, how the scoring worked, and whether the process adequately addressed social equity were features of the program throughout its medical-only years. This is the infrastructure that operators like Shangri-La built their businesses on starting in 2019.
Patient Demographics and Growth
Ohio's medical marijuana program served hundreds of thousands of patients across its medical-only years. Patient registrations climbed steadily through 2019, 2020, and 2021 as awareness grew and additional qualifying conditions were added. The program matured into a functioning medical infrastructure with dispensaries across the state's major population centers, including Hamilton County.
Issue 2 and the Adult-Use Transition
When voters approved Issue 2 in November 2023, the medical program was not eliminated. Instead, the statute created an adult-use market alongside the medical program, with many licensed medical operators transitioning their licenses into combined medical-and-adult-use retail.
The practical effect for patients: Ohio medical marijuana patients can still register, still receive patient IDs, and still receive patient benefits at dispensaries — including exemption from the 10% adult-use excise tax, higher purchase limits measured in 90-day supply terms, and access to medical-specific product lines at some shops.
The practical effect for operators: dispensaries that had built their business on medical sales now served two overlapping customer populations from the same storefront. The best operators — including longstanding medical-era companies like Shangri-La — carried their medical-era retail discipline (product education, compliance, patient service) into the adult-use market, which is part of why those operators are consistently strong in customer reviews.
The OMMCP Is Rebranded, Not Gone
The Ohio Medical Marijuana Control Program (OMMCP) was consolidated under the new Ohio Division of Cannabis Control (DCC) within the Department of Commerce. The DCC now administers both the medical and adult-use programs, licenses operators across both categories, and handles compliance and enforcement for the entire Ohio cannabis market.
Why the Medical Story Matters in 2026
If you are a Cincinnati cannabis consumer in 2026 — shopping at a Hamilton County dispensary for either adult-use or medical cannabis — you are benefiting from infrastructure and professional norms that were established between 2019 and 2024 under the medical program. The fact that Ohio dispensaries open at 8 AM and close at 10 PM, stock consistent product, apply child-resistant packaging across every SKU, run Dutchie-enabled menus and loyalty programs, and train staff for product consultation — all of that is inheritance from the medical era.
For the hundreds of thousands of Ohio medical patients who relied on the program before 2024, the continued existence of medical-specific pricing, higher caps, and tailored support reflects a recognition that medical cannabis is a distinct retail category from adult-use. It's not the same product relationship. And Ohio has — so far — chosen to preserve it.